Rheumatology
Rheumatological conditions often intersect with osteoporosis, creating unique challenges for patient care. This session will explore the management of osteoporosis in patients with rheumatoid arthritis, lupus, and other rheumatic diseases. Experts will discuss the impact of chronic inflammation on bone density and fracture risk, as well as the latest therapies aimed at controlling both rheumatic disease activity and osteoporosis. Attendees will learn about emerging biologics, corticosteroid-sparing treatments, and strategies for reducing fracture risk while managing systemic inflammatory conditions. The session aims to provide a holistic approach to care.
Key Highlights:
- Osteoporosis in rheumatic diseases
- Chronic inflammation’s impact on bone health
- Biologic therapies for dual conditions
- Corticosteroid-sparing strategies
- Comprehensive treatment for osteoporotic patients